Clinical trial

Same-day Antiretroviral Therapy With BIC/F/TAF

NCT04712058

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-01-20

PhaseNA

Study timeline

Study start (estimated)2021-01-20Date precision: day

Registry last updated2021-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Bictegravir / Emtricitabine / Tenofovir Alafenamide Oral Tablet [Biktarvy]DRUG · verified · RxNorm: bictegravir / emtricitabine / tenofovir alafenamide Oral Tablet [Biktarvy]

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

Far Eastern Memorial Hospitalcollaborator

Mackay Memorial Hospitalcollaborator

Changhua Christian Hospitalcollaborator

Chung Shan Medical Universitycollaborator

National Cheng-Kung University Hospitalcollaborator

Chi Mei Medical Hospitalcollaborator

Kaohsiung Medical University Chung-Ho Memorial Hospitalcollaborator

Kaohsiung Municipal Ta-Tung Hospitalcollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04712058 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.